77.1%
in situ immunotherapycancerELI-004ELI-002
…cific products. To circumvent these challenges and limitations, in situ immunotherapy administers immunostimulatory adjuvants directly into tumors, w…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 1,981–2,040 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
Adaptive digital therapy1Adaptive radiotherapy1Adhesiolysis1Adjuvant External Beam Radiation Therapy1Adoptive CTL therapy1Adoptive T cell immunotherapy1Adoptive TIL therapy1Adoptive cell therapy (ACT)1Adoptive cell transfer-based immunotherapy1Adrenal surgery1Airway clearance techniques1Alcohol consumption1Allo-HCT1Allogeneic haematopoietic stem cell transplant1Allogeneic stem-cell transplant1Allogeneic stem-cell transplantation1Ambulatory consolidation therapy1Amputation1Anaesthetic management1Analgesic patch1Angioembolisation1Angioembolization1Ankle blocks1Anti-Aβ therapies1Anti-TNF α treatment1Anti-amyloid therapies1Anti-programmed cell death protein 1 (PD-1) antibody therapy1Anti-programmed cell death protein 1 (PD-1) immunotherapy1Antibiotic use271Antibody therapeutics1Anticonvulsant therapy41Antidiabetic treatment1Antihistamine therapy1Antiplatelet management1Antithrombotic treatment1Antithrombotic treatment strategy1Antituberculosis therapy1Apreo BREATHE Airway Scaffold1Arthroscopic shoulder surgery1Artisse intrasaccular device1At-home subcutaneous immunoglobulin treatment1Atez/Bev1Auricular vagal neuromodulation therapy1Auriculotemporal nerve block1Autologous CAR-T cell therapies1Autologous hamstring tendon grafts1Autologous hematopoietic stem cell transplant1Autologous tumor-infiltrating lymphocyte (TIL) therapy1B cell-targeted therapies1B-cell depleting biologic therapies1B-cell depleting treatment1B-cell targeted therapy1B7-H3-directed CAR T-cell therapy1BCAA supplementation1BCG therapy1BCMA-targeting CAR-T cell therapy1BEL1BEL-based triple therapy1BIC-based triple therapies1BLV1
Articles mentioning treatments
7,227 articles · page 505 of 603anti-PD-1/PD-L1 therapiesThe Ohio State University Comprehensive Cancer CenterMerkel cell carcinomaOSUCCCPelotonia Institute for Immuno-OncologyMCCNational Institutes of HealthNIH
…ltration, MCC tumors often evade immune-mediated killing. While anti-PD-1/PD-L1 therapies are efficacious, MCC patients resistant or relapsing after immu…
adjuvant immunotherapiesLung cancer
…omarkers predictive of the likelihood of patients responding to adjuvant immunotherapies. Briefly, we applied cell segmentation and unbiased cell typing…
immune checkpoint blockadehepatocellular carcinomaUniversity of WashingtonFred Hutch Cancer CenterhAbChAbCs
…e PD1+ CXCL13+ T helper and TCF7+ progenitor CD8+ T cells after immune checkpoint blockade, suggesting interactions between these cells can overcome T cel…
TKIsselpercatinibcabozantinibvandetanibNew England Journal of MedicineClinical Cancer ResearchMedullary thyroid cancer (MTC)EACRIUC-DenverGFRA4+1 more
…r metastatic MTC. In the setting of progressive metastatic MTC, TKIs (selpercatinib, cabozantinib and vandetanib) can prolong surviv…
Chimeric Antigen Receptor T (CAR-T) cell therapyhematologic malignanciessolid tumors
…Background Chimeric Antigen Receptor T (CAR-T) cell therapy has emerged as an advanced and highly effective approach for tr…
combination chemotherapypancreatic cancerADoBindADoBind-MMAEADoBind-DM1MC001
…s than 50% of patients with advanced pancreatic cancer tolerate combination chemotherapy. Combining immune-mediated cytotoxicity with payload-mediated c…
epidural analgesiaVisual Analogue ScalesufentanilropivacaineFirst Affiliated Hospital of Soochow UniversityERMF
…ndomised controlled trial will enrol 424 parturients undergoing epidural analgesia for trial of labour. Participants will be randomised (1:1) to r…
immunomodulatory treatmentNintedanibHospital District of Helsinkiinterstitial lung disease (ILD)connective tissue disease–ILDs
…100 mg two times per day). Twenty-seven (87%) patients received immunomodulatory treatment at the time of PPF.Conclusions In our cohort, the underlying di…
non-invasive ventilationcerebral palsyCPCYP
…piratory support (continuous positive airway pressure (CPAP) or non-invasive ventilation) to aid airway clearance. 1 2 Published evidence is sparse.1 2 …
mannose-based dietgastro-oesophageal reflux diseasehypothyroidismauditory neuropathy
… in MOGS CDG (congenital disorder of glycosylation type IIb). A mannose-based diet led to partial improvement. This case highlights the importance…
MDItype 1 diabetesGAD-7diabetesGeneralized Anxiety Disorder-7
…action than CSII users (p=0.044) and lower diabetes burden than MDI users (p=0.044) after controlling for age and gender. Treatment…